{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T23:32:09Z","timestamp":1721604729268},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T00:00:00Z","timestamp":1461283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s10157-016-1267-7","type":"journal-article","created":{"date-parts":[[2016,4,22]],"date-time":"2016-04-22T04:22:28Z","timestamp":1461298948000},"page":"152-158","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Pharmacokinetics of mycophenolic acid in children with clinically stable idiopathic nephrotic syndrome receiving cyclosporine"],"prefix":"10.1007","volume":"21","author":[{"given":"Satoshi","family":"Hibino","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuhito","family":"Nagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yamakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidekazu","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osamu","family":"Uemura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,4,22]]},"reference":[{"key":"1267_CR1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362:629\u201339.","journal-title":"Lancet"},{"key":"1267_CR2","doi-asserted-by":"crossref","unstructured":"Ishikura K, Ikeda M, Hattori S, Yoshikawa N, Sasaki S, Iijima K, Nakanishi K, Tata N, Honda M, for Japanese Study group of Renal Disease in Children. Effective and safe treatment with cyclosporine in nephrotic children: a prospective, randomized multicenter trial. Kidney Int. 2008;73:1167\u201373.","DOI":"10.1038\/ki.2008.24"},{"key":"1267_CR3","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1038\/ki.1993.194","volume":"43","author":"C Ponticelli","year":"1993","unstructured":"Ponticelli C, Rizzoni G, Edefonti A, Altieri P, Rivolta E, Rinaldi S, Ghio L, Lusvarghi E, Gusmano R, Locatelli F, Pasquali S, Castellani A, Casa-Alberighi OD. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int. 1993;43:1377\u201384.","journal-title":"Kidney Int"},{"key":"1267_CR4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00467-012-2278-6","volume":"28","author":"S Banerjee","year":"2013","unstructured":"Banerjee S, Pahari A, Sengupta J, Patnaik SK. Outcome of severe steroid-dependent nephrotic syndrome treated with mycophenolate mofetil. Pediatr Nephrol. 2013;28:93\u20137.","journal-title":"Pediatr Nephrol"},{"key":"1267_CR5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00467-009-1375-7","volume":"25","author":"Z Li","year":"2010","unstructured":"Li Z, Duan C, He J, Wu T, Xun M, Yi Z, Yin Y. Mycophenolate mofetil therapy for children with steroid-resistant nephrotic syndrome. Pediatr Nephrol. 2010;25:883\u20138.","journal-title":"Pediatr Nephrol"},{"key":"1267_CR6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/ped.12498","volume":"57","author":"S Hibino","year":"2015","unstructured":"Hibino S, Uemura O, Nagai T, Yamakawa S, Iwata N, Ito H, Nakano M, Tanaka K. Three year outcome of childhood idiopathic nephrotic syndrome under a unified immunosuppressive protocol. Pediatr Int. 2015;57:85\u201391.","journal-title":"Pediatr Int"},{"key":"1267_CR7","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00467-006-0294-0","volume":"22","author":"S Fujinaga","year":"2007","unstructured":"Fujinaga S, Ohtomo Y, Umino D, Takemoto M, Shimizu T, Yamashiro Y, Kaneko K. A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome. Pediatr Nephrol. 2007;22:71\u20136.","journal-title":"Pediatr Nephrol"},{"key":"1267_CR8","first-page":"925","volume":"28","author":"RE Bullingham","year":"1996","unstructured":"Bullingham RE, Nicholls A, Hale M. Pharmacokinetics of mycophenolate mofetil (RS61443): a short review. Transpl Proc. 1996;28:925\u20139.","journal-title":"Transpl Proc."},{"key":"1267_CR9","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/01.ASN.0000027031.79843.6C","volume":"13","author":"LT Weber","year":"2002","unstructured":"Weber LT, Shipkova M, Armstrong VW, Wagner N, Schutz E, Mehils O, Zimmerhackl LB, Oellerich M, Tonshoff B. The pharmacokinetic-pharmacodynamic relationship for total and free mycophenolic acid in pediatric renal transplant recipients: a report of the german study group on mycophenolate mofetil therapy. J Am Soc Nephrol. 2002;13:759\u201368.","journal-title":"J Am Soc Nephrol"},{"key":"1267_CR10","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1365-2125.2012.04213.x","volume":"74","author":"C Barau","year":"2012","unstructured":"Barau C, Furlan V, Debray D, Taburet AM, Barrail-Tran A. Population pharmacokinetics of mycophenolic acid and dose optimization with limited sampling strategy in liver transplant children. Br J Clin Pharmacol. 2012;74:515\u201324.","journal-title":"Br J Clin Pharmacol"},{"key":"1267_CR11","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0009-9236(98)90058-3","volume":"64","author":"MD Hale","year":"1998","unstructured":"Hale MD, Nicholls AJ, Bullingham RE, Hen\u00e9 R, Hoitsma A, Squifflet JP, Weimar W, Vanrenterghem Y, Van de Woude FJ, Verpooten GA. The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation. Clin Pharmacol Ther. 1998;64:672\u201383.","journal-title":"Clin Pharmacol Ther"},{"key":"1267_CR12","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1093\/clinchem\/47.7.1241","volume":"47","author":"M Mourad","year":"2001","unstructured":"Mourad M, Malasie J, Chaib Eddour D, De Meyer M, K\u00f6nig J, Schepers R, Squiffet JP, Wallemacq P. Pharmacokinetic basis for the efficient and safe use of low-dose mycophenolate mofetil in combination with tacrolimus in kidney transplantation. Clin Chem. 2001;47:1241\u20138.","journal-title":"Clin Chem"},{"key":"1267_CR13","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00467-011-2006-7","volume":"27","author":"V Baudouin","year":"2012","unstructured":"Baudouin V, Alberti C, Lapeyraque AL, Bensman A, Andr\u00e9 JL, Broux F, Calilliez M, Decramer S, Niaudet P, Desch\u00eanes G, Jacqz-Aigrain E, Loirat C. Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trial. Pediatr Nephrol. 2012;27:389\u201396.","journal-title":"Pediatr Nephrol"},{"key":"1267_CR14","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1365-2125.2010.03615.x","volume":"69","author":"W Zhao","year":"2010","unstructured":"Zhao W, Elie V, Baudouin V, Bensman A, Andr\u00e9 JL, Brochard K, Broux F, Cailliez M, Loirat C, Jacqz-Aigrain E. Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome. Br J Clin Pharmacol. 2010;69:358\u201366.","journal-title":"Br J Clin Pharmacol"},{"key":"1267_CR15","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1681\/ASN.2012121200","volume":"24","author":"J Gellermann","year":"2013","unstructured":"Gellermann J, Weber L, Pape L, T\u00f6nshoff B, Hoyer P, Querfeld U. Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol. 2013;24:1689\u201397.","journal-title":"J Am Soc Nephrol"},{"key":"1267_CR16","doi-asserted-by":"crossref","unstructured":"Aint-Marcoux F, Guigonis V, Decramer S, Gandia P, Ranchin B, Parant F, bessenay L, Libert F, Harambat J, Bouchet S, Broux F, Compagnon P, Marquet P. Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome. Pharmacol Res. 2011;63:423\u201331.","DOI":"10.1016\/j.phrs.2011.01.009"},{"key":"1267_CR17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1681\/ASN.2005101070","volume":"17","author":"RM Hest van","year":"2006","unstructured":"van Hest RM, Mathot RA, Pescovitz MD, Gordon R, Mamelok RD, van Gelder T. Explaining variability in mycophenolic acid exposure to optimize mycophenolate mophetil dosing: a population pharmacokinetic meta-analysis of mycophenoric acid in renal transplant recipients. J Am Coc Nephrol. 2006;17:871\u201380.","journal-title":"J Am Coc Nephrol."},{"key":"1267_CR18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/lt.20124","volume":"10","author":"JM Tredger","year":"2004","unstructured":"Tredger JM, Brown NW, Adams J, Gonde CE, Dhawan A, Rela M, Heaton N. Monitoring mycophenolate in liver transplant recipients: toward a therapeutic range. Liver Transpl. 2004;10:492\u2013502.","journal-title":"Liver Transpl"},{"key":"1267_CR19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s004670050021","volume":"14","author":"G Filler","year":"2000","unstructured":"Filler G, Zimmering M, Mai I. Pharmacokinetics of mycophenolate mofetil are influenced by concomitant immunosuppression. Pediatr Nephrol. 2000;14:100\u20134.","journal-title":"Pediatr Nephrol"},{"key":"1267_CR20","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1097\/00007890-199911270-00028","volume":"68","author":"PJ Gregoor","year":"1999","unstructured":"Gregoor PJ, de S\u00e9vaux RG, Hen\u00e9 RJ, Hesse CJ, Hilbrands LB, Vos P, van Gelder T, Hoitsma AJ, Weimar W. Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients. Transplantation. 1999;68:1603\u20136.","journal-title":"Transplantation"},{"key":"1267_CR21","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1177\/0091270003256151","volume":"43","author":"DR Kuypers","year":"2003","unstructured":"Kuypers DR, Claes K, Evenepoel P, Maes B, Coosemans W, Pirenne J, Vanrenterghem Y. Long-term changes in mycopherolic acid exposure in combination with tacrolimus and corticosteroids are dose dependent and not reflected by trough plasma concentration: a prospective study in 100 de novo renal allograft recipients. J Clin Pharmacol. 2003;43:866\u201380.","journal-title":"J Clin Pharmacol"},{"key":"1267_CR22","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1016\/j.transproceed.2012.09.063","volume":"44","author":"CJM Vergara","year":"2012","unstructured":"Vergara CJM, S\u00e1ez-Benito GA, Zopeque GN, Garc\u00eda PS, Joumady I, Carrasco GC, Vara GF. Analytical validation of a homogeneous immunoassay for determination of mycophenolic acid in human plasma. Transpl Proc. 2012;44:2669\u201372.","journal-title":"Transpl Proc."},{"key":"1267_CR23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0009-9120(03)00011-0","volume":"36","author":"AW Butch","year":"2003","unstructured":"Butch AW, Fukuchi AM. Evaluation of a new pretreatment reagent for use with the EMT 2000 cyclosporine assay. Clin Biochem. 2003;36:313\u20136.","journal-title":"Clin Biochem"},{"key":"1267_CR24","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1007\/s10157-013-0856-y","volume":"18","author":"O Uemura","year":"2014","unstructured":"Uemura O, Nagai T, Ishikura K, Ito S, Hataya H, Gotoh Y, Fujita N, Akioka Y, Kaneko T, Honda M. Creatinine-based equation to estimate the glomerular filtration rate in Japanese children and adolescents with chronic kidney disease. Clin Exp Nephrol. 2014;18:626\u201333.","journal-title":"Clin Exp Nephrol."},{"key":"1267_CR25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2165\/00003088-199834060-00002","volume":"34","author":"RE Bullingham","year":"1998","unstructured":"Bullingham RE, Nicholls AJ, Kamm BR. Clinical pharmacokinetics of mycophenolate mofetil. Clin Pharmacokinet. 1998;34:429\u201355.","journal-title":"Clin Pharmacokinet"},{"key":"1267_CR26","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00007691-200104000-00005","volume":"23","author":"T Gelder van","year":"2001","unstructured":"van Gelder T, Klupp J, Barten MJ, Christians U, Morris RE. Comparison of the effects of tacrolimus and cyclosporine on pharmacokinetics of mycophenolic acid. Ther Drug Monit. 2001;23:119\u201328.","journal-title":"Ther Drug Monit"},{"key":"1267_CR27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00007691-200004000-00005","volume":"22","author":"G Filler","year":"2000","unstructured":"Filler G, Mai I. Limited sampling strategy for mycophenolic acid area under the curve. Ther Drug Monit. 2000;22:169\u201373.","journal-title":"Ther Drug Monit"},{"key":"1267_CR28","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00228-001-0389-2","volume":"57","author":"C Guellec Le","year":"2002","unstructured":"Le Guellec C, B\u00fcchler M, Giraudeau B, Le Meur Y, Gakou\u00e9 JE, Lebranchu Y, Marquet P, Paintaud G. Simultaneous estimation of cyclosporine and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy. Eur J Clin Pharmacol. 2002;57:805\u201311.","journal-title":"Eur J Clin Pharmacol"},{"key":"1267_CR29","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/clinchem\/48.9.1497","volume":"48","author":"T Pawinski","year":"2002","unstructured":"Pawinski T, Hale M, Korecka M, Fitzsimmons WE, Shaw LM. Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus. Clin Chem. 2002;48:1497\u2013504.","journal-title":"Clin Chem"},{"key":"1267_CR30","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/00007890-200101270-00009","volume":"71","author":"C Chardot","year":"2001","unstructured":"Chardot C, Nicoluzzi JE, Janssen M, Sokal E, Lerut J, Otte JB, Reding R. Use of mycophenolate mofetil as rescue therapy after pediatric liver transplantation. Transplantation. 2001;71:224\u20139.","journal-title":"Transplantation"},{"key":"1267_CR31","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1681\/ASN.V981511","volume":"9","author":"LT Weber","year":"1998","unstructured":"Weber LT, Shipkova M, Lamersdorf T, Niedmann PD, Wiesel M, Mandelbaum A, Zimmerhackl LB, Sch\u00fctz E, Mehls O, Oellerich M, Armstrong VW, T\u00f6nshoff B. Pharmacokinetics of mycophenolic acid (MPA) and determination of MPA free fraction in pediatric and adult renal transplant recipients. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients. J Am Soc Nephrol. 1998;9:1511\u201320.","journal-title":"J Am Soc Nephrol"},{"key":"1267_CR32","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/j.transproceed.2004.05.043","volume":"36","author":"G Filler","year":"2004","unstructured":"Filler G, Foster J, Berard R, Mai I, Lepage N. Age-dependency of mycophenolate mofetil dosing in combination with tacrolimus after pediatric renal transplantation. Transpl Proc. 2004;36:1327\u201331.","journal-title":"Transpl Proc."},{"key":"1267_CR33","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.bbmt.2009.10.007","volume":"16","author":"M Bhatia","year":"2010","unstructured":"Bhatia M, Militano O, Jin Z, Figurski M, Shaw L, Moore V, Morris E, Tallamy B, van deVen C, Ayello J, Baxter-Lowe L, Satwani P, George D, Bradley MB, Garvin J, Cairo MS. An age-dependent pharmacokinetic study of intravenous and oral mycophenolate mofetil in combination with tacrolimus for GVHD prophylaxis in pediatric allogeneic stem cell transplantation recipients. Biol Blood Marrow Transpl. 2010;16:333\u201343.","journal-title":"Biol Blood Marrow Transpl."},{"key":"1267_CR34","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","volume":"349","author":"GL Kearns","year":"2003","unstructured":"Kearns GL, Abdel-Rahman SM, Alander SW, Blowey DL, Leeder JS, Kauffman RE. Developmental pharmacology-drug disposition, action, and therapy in infants and children. N Engl J Med. 2003;349:1157\u201367.","journal-title":"N Engl J Med"},{"key":"1267_CR35","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1542\/pir.26-9-321","volume":"26","author":"M Tetelbaum","year":"2005","unstructured":"Tetelbaum M, Finkelstein Y, Nava-Ocampo AA, Koren G. Back to basics: understanding drugs in children: pharmacokinetic maturation. Pediatr Rev. 2005;26:321\u20138.","journal-title":"Pediatr Rev"},{"key":"1267_CR36","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1046\/j.1523-1755.2002.00531.x","volume":"62","author":"D Cattaneo","year":"2002","unstructured":"Cattaneo D, Perico N, Gaspari F. Glucocorticoids interfere with mycophenolate mofetil bioavailability in kidney transplantation. Kidney Int. 2002;62:1060\u20137.","journal-title":"Kidney Int"},{"key":"1267_CR37","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1097\/FTD.0b013e31818752d9","volume":"30","author":"LT Weber","year":"2008","unstructured":"Weber LT, Hoecker B, Armstrong VW, Oellerich M, T\u00f6nshoff B. Long-term pharmacokinetics of mycophenolic acid in pediatric renal transplant recipients over 3\u00a0years posttransplant. Ther Drug Monit. 2008;30:570\u20135.","journal-title":"Ther Drug Monit"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1267-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-016-1267-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1267-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-016-1267-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T10:46:57Z","timestamp":1655549217000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-016-1267-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,22]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["1267"],"URL":"https:\/\/doi.org\/10.1007\/s10157-016-1267-7","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,22]]}}}